TrialJournal of neurology, neurosurgery, and psychiatry2020

Consistent control of disease activity with fingolimod versus IFN β-1a in paediatric-onset multiple sclerosis: further insights from PARADIG

Kumaran Deiva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.